Bioworld Financial Watch articles from December 2002

Bioworld Financial Watch archives from December 2002

Myriad's predictive medicine, therapy push go 'hand in hand'.
December 2, 2002... The field of predictive medicine, one subsector in which the largely faded near-term promise of genomics maintains its color, is just where Myriad Genetics Inc. has wanted to be from the start - but not the only place. With a handful of...

10 biggest U.S. gainers and losers for the week.
December 2, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Neurobio Tech 51.73 Genaissance 47.54 3D Pharma 44.48 Peregrine Pharma 42.86 Sonus Pharma 38.94 Oxis Int'l 38.46 Curis...

Biotech corporate collaborations in agriculture: new, revised agreements, May 31 -- Nov. 26, 2002.
December 2, 2002... Biotech Corporate Collaborations In Agriculture: New, Revised Agreements, May 31 -- Nov. 26, 2002 Biotech Co. * Agbiotech (Country; Partner (Country; Symbol) Symbol) Amarillo Chihiro Sugimoto...

BioWorld stock report for public biotechnology companies.
December 2, 2002... BioWorld Stock Report For Public Biotechnology Companies % Change Close Close Vol * Company Symbol 11/22 11/27 WK ...

Money raised by biotech in 2002 Vs. 2001.
December 2, 2002... Money Raised By Biotech In 2002 Vs. 2001 Millions Jan. 1 - Nov. 26, Jan. 1 - Nov. 29, 2002: $9,533.32M 2001: $11,585M Public/Other * 5,191 ...

Analyst: Gilead/Triangle's HIV drug, facing GSK's, may need more trials.
December 9, 2002... Almost as if to provide a metaphor for HIV treatment strategy - drug combination is the weapon of choice for fighting the infection - two major players said last week they plan to join forces in a $464 million merger whereby Gilead Sciences...

Money raised by biotech.
December 9, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - Dec. 5, 2002: Jan. 1 - Dec. 6, 2001: $9,697.5M $13,085.1M Public/Other * 6,263 5,523 Private...

10 biggest U.S. gainers & losers for the week.
December 9, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Miravant 55.56 Immune Resp 53.16 Sheffield 50.00 Siga Technol 45.45...

Public financing of Biotechnology.
December 9, 2002... Public Financing Of Biotechnology: November 2002 1. COMMENCED TRADING IN NOVEMBER Company Date Date Shares/ Price Shares (Symbol) Filed Comm. Units (M) Out ...

Other financings of Public Biotechnology Companies.
December 9, 2002... Other Financings Of Public Biotechnology Companies: November 2002 TOTAL: $238,456M Company Type Of Number Of Amount (Symbol) # Financing Shares, Units Raised ...

Venture Capital and Corporate Investments in Biotechnology Companies.
December 9, 2002... Venture Capital And Corporate Investments In Biotechnology Companies: November 2002 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $167.735M Company Location Date Amt. (M) Altea Atlanta ...

Money raised by Biotech in 2002.
December 9, 2002... Money Raised By Biotech In 2002: January-November Type of I ($M) F ($M) M ($M) A ($M) M ($M) I ($M) financing Public offerings 73.1 345.8 156.9 325.0 21.8 69.6 Private biotechs 341.0 241.6...

BioWorld Stock Indicator 2002.
December 9, 2002... These graphs compare the performance of the biotech stocks in 2002 using two different measures. The BioWorld Stock Indicator measures the average percent change year-to-date in the 276 U.S. biotech and biotech-related stocks that are...

BioWorld stock report for Public Biotechnology Companies.
December 9, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 11/27 12/6 WK YTD 3D Pharma DDDP 4.45 3.21 ...

Proposed SEC rule would ease young firms' investment rules.
December 16, 2002... The Securities and Exchange Commission is mulling a rule change that would allow biotechnology firms more flexibility to invest, so they can better advance research and development -- and in Washington, the industry push is on for a somewhat...

Money raised by biotech in 2002 vs. 2001.
December 16, 2002... Money Raised By Biotech In 2002 Vs. 2001 Public/ Private Public Other * Biotechs Offerings Millions...

10 biggest U.S. gainers for the week.
December 16, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Northwest Bio Thera 100.00 Invitrogen 3.61 DOR BioPharma 42.86 Gen-Probc 1.40 Aastrom Biosci 37.21 Neurobio Tcch 1.10...

10 biggest U.S. losers for the week.
December 16, 2002... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (BY Dollars) NaPro Biother -45.32 VaxGen -6.14 ArQule -44.56 Trimeris -3.81 Pharsight -42.31 Cephalon -3.77 Avigen ...

Correction.
December 16, 2002... An item in the Venture Capital section of the Dec. 9, 2002, issue of BioWorld Financial Watch neglected to list Oxford Bioscience Partners as a co-lead investor along with HealthCare Ventures LLC in a $13.25 million first-round financing for...

Clinical trial update.
December 16, 2002... Clinical Trial Update: November 2002 Company * Product (Country; Symbol) AUTOIMMUNE Biogen Inc. Amevive (BGEN) Serono SA Rebif (NYSE:SRA) and ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals.
December 16, 2002... Non-U.S. Clinical Trials Regulatory Submissions, Recommendations And Approvals: November 2002 Company * Product Description (Country; Symbol) AUTOIMMUNE Corixa Corp. (CRXA) PVAC ...

FDA submissions, approvals and other actions.
December 16, 2002... FDA Submissions, Approvals And Other Actions: November 2002 Company * Product Description (Country; Symbol) CANCER EntreMed Inc. ENMD 0995 A new derivative of (ENMD) ...

BioWorld stock report for Public Biotechnology Companies.
December 16, 2002... BioWorld Stock Report For Public Biotechnology Companies Close Close % Change Company Symbol 12/6 12/13 WK YTD 3D Pharma DDDP 3.21 3.061 ...

London stock exchange.
December 16, 2002... LONDON STOCK EXCHANGE Company Symbol 12/6 12/13 %WK %YTD Volume Acambis ACM 243.5 271.5 11.50 -22.54 923 Antisoma ASM 30.25 28.5 -5.79 -19.72 3028 British Biotech BBG...

Toronto stock exchange.
December 16, 2002... TORONTO STOCK EXCHANGE Company Symbol 12/6 12/13 %WK %YTD Volume Adherex AHX 0.37 0.39 5.41 -7.14 184 Angiotech Pharma ANP 57.81 55.25 -4.43 -37.92 183 Anormed ...

FDA panels provide late-year cheer with FluMist, Bexxar nods.
December 23, 2002... Talk about a shot in the arm (or a squirt up the nose): The ailing biotechnology sector got a boost last week when FDA advisory panels gave their blessings to a pair of potentially important but historically beleaguered drugs--Corixa corp.'s...

10 Biggest U.S. Gainers & Losers for the Week.
December 23, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) V.I. Technol 60.49 Pharsight 60.00 Valentis 58.24 Demegen 50.00 Cypress 39.30 Aphton 35.21 Incara Pharma 28.57 Lexicon...

Biotech -- Big Pharma Collaborations: New Agreements, Oct. 24 -- Dec. 18, 2002 #.
December 23, 2002... Biotech - Big Pharma Collaborations: New Agreements, Oct. 24 - Dec. 18, 2002 # Biotech Co. * Pharma Co. (Country; (Country) Symbol) AdipoGenix Johnson & Inc. * Johnson Pharma- ...

Manufacturing, Marketing and Distribution Agreements Between Biotech and Pharmaceutical Companies: Oct. 24 -- Dec. 18, 2002 #.
December 23, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotech and Pharmaceutical Companies: Oct. 24 - Dec. 18, 2002 # Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Cobra...

Biotech -- Big Pharma Collaborations: Modified and Terminated Agreements, Oct. 24 -- Dec. 18, 2002 #.
December 23, 2002... Biotech - Big Pharma Collaborations: Modified And Terminated Agreements, Oct. 24 - Dec. 18, 2002 # I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; (Country) agreement...

BioWorld Stock Report for Public Biotechnology Companies.
December 23, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 12/13 12/20 WK YTD 3D Pharma DDDP 3.061 3.05...

London Stock Exchange.
December 23, 2002... LONDON STOCK EXCHANGE Company Symbol 12/13 12/20 %WK %YTD Volume Acambis ACM 271.5 282.5 -3.31 -25.11 3686 Antisoma ASM 28.5 29.25 2.63 -17.61 12627 British Biotech BBG...

Toronto Stock Exchange.
December 23, 2002... TORONTO STOCK EXCHANGE Company Symbol 12/13 12/20 %WK %YTD Volume Adherex AHX 0.39 0.4 2.56 -4.76 148 Angiotech Pharma ANP 55.25 53.1 -3.89 -40.34 325 Anormed ...

ArQule moving biology forward as it moves to drug discovery.
December 30, 2002... The nitty-gritty of deal making and how strategy fits (or fails to fit) with business models became topics this month when ArQule Inc.'s much-hoped-for collaboration with an unnamed partner fell through, and the company said it was cutting its...

Money raised by Biotech.
December 30, 2002... Money Raised By Biotech In 2002 Vs. 2001 Jan. 1 - Dec. 26, Jan. 1 - Dec. 26, 2002: $9,922.35M 2002: $,922.35M Public/Other * 5,352 6,114 Private Biotechs ...

10 biggest U.S. gainers & losers for the week.
December 30, 2002... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) LION bioscience 68.00 Neurocrine Biosci 3.00 Axonyx 40.00 LION bioscience 2.55 Essential Thera 37.66 VaxGen ...

Biotechnology company deals with other Biotechnology companies: collaborations, agreements, equity participation.
December 30, 2002... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Oct. 31 - Dec. 23, 2002 # Company * Company * (Country; (Country; Symbol) Symbol) ...

Biotechnology company deals with Miscellaneous companies: collaborations, agreements, equity participation.
December 30, 2002... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Oct. 31-Dec. 23, 2002 # Company * Company * Type/Product Area (Country; Symbol) (Country) Aastrom...

Manufacturing, marketing and distribution agreements between Biotech companies.
December 30, 2002... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Oct. 31 - Dec. 23, 2002 # Company * Company * Product (Country; (Country; Symbol) Symbol) Discovery ...

Biotech -- Biotech collaborations: modified and terminated agreements.
December 30, 2002... Biotech -- Biotech Collaborations: Modified And Terminated Agreements, Oct. 31 - Dec. 23, 2002 # I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; agreement...

BioWorld stock report for Public Biotechnology Companies.
December 30, 2002... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 12/20 12/27 WK YTD 3D Pharma DDDP 3.05 3.1 ...

London Stock Exchange.
December 30, 2002... LONDON STOCK EXCHANGE Company Symbol 12/20 12/27 %WK %YTD Volume * Acambis ACM 262.5 265.5 1.14% -24.25% 281 Antisoma ASM 29.25 29 -0.85% -18.31% 218 British Biotech ...

Toronto Stock Exchange.
December 30, 2002... TORONTO STOCK EXCHANGE Company Symbol 12/20 12/27 %WK %YTD Volume * Adherex AHX 0.4 0.405 1.25% -3.57% 41 Angiotech Pharma ANP 53.1 53.9 1.51% -39.44% 49...